Pan African Medical Journal
Journal / Pan African Medical Journal / Vol. 37 No. 1 (2020) / Articles

download PDF

Published:

Dec 23, 2020

Keywords:

Mucosa-associated lymphoid tissue, lymphoma, prognosis, treatment

Issue

Vol. 37 No. 1 (2020)

Section

Articles

Brief summary of the agreement Anyone is free: · to copy, distribute, and display the work; · to make derivative works; · to make commercial use of the work; Under the following conditions: Attribution · the original author must be given credit; · for any reuse or distribution, it must be made clear to others what the license terms of this work are; · any of these conditions can be waived if the authors gives permission. Statutory fair use and other rights are in no way affected by the above

Yosr Zenzri

Pathology Department, Salah Azaiez Institute, Tunis, Tunisia

Lamia Charfi

Pathology Department, Salah Azaiez Institute, Tunis, Tunisia

Ghada Sahraoui

Pathology Department, Salah Azaiez Institute, Tunis, Tunisia

Yosra Yahyaoui

Medical Oncology Department, Salah Azaiez Institute, Tunis, Tunisia

Karima Mrad

Pathology Department, Salah Azaiez Institute, Tunis, Tunisia

Nadia Boujelbene

Pathology Department, Salah Azaiez Institute, Tunis, Tunisia

Raoudha Doghri

Pathology Department, Salah Azaiez Institute, Tunis, Tunisia

Abstract

The stomach is the most frequent site of extranodal lymphoma. Mucosa-associated lymphoid tissue (MALT) lymphoma is a low-grade, B-cell neoplasm strongly associated with Helicobacter pylori (HP) infection. The presenting complaints of gastric MALT lymphoma are usually nonspecific. HP eradication is regarded as the first-line therapy in early stage disease. Management of patients who failed to achieve remission following HP eradication include chemotherapy, radiotherapy and in selected cases, surgery. The aim of the present study was to examine the clinical characteristics and treatment outcome of patients with gastric MALT lymphoma.

Journal Identifiers

eISSN: 1937-8688